The BSCMR Board brings together experienced clinicians, and trainees dedicated to advancing cardiovascular magnetic resonance in the UK.

Our board members lead the Society’s strategic direction, promote collaboration within the CMR community, and support education, research, and innovation. Together, they ensure that BSCMR continues to represent and inspire excellence in CMR practice and development.

Prof. Saul Myerson is a consultant cardiologist at the John Radcliffe Hospital in Oxford, and is the clinical lead for cardiac imaging. He is also an honorary senior clinical lecturer at the University of Oxford, and Lecturer in Medicine at St. Catherines College, Oxford. He specialises in non-invasive cardiac imaging, particularly cardiovascular magnetic resonance, and his clinical and research interests are in valve disease, aortic disease and cardiomyopathies. He qualified from the University of Bristol and completed further training in London and Oxford. He has published widely, has given many national and international lectures and is editor of the Oxford Handbooks of Cardiology Emergencies, Valve Disease and Cardiovascular Magnetic Resonance. He was president of the British Junior Cardiologists Association from 2005-2007.

Dr Keenan is a consultant cardiologist at West Herts NHS Trust as well as an honorary consultant cardiologist at Hammersmith Hospital, and an Honorary Lecturer at Imperial College, London. He qualified from Oxford University in 2001 and then trained in cardiology and general medicine in London. He carried out specialised training and research in cardiac MRI at the Royal Brompton Hospital, in cardiac CT at the London Chest Hospital, and in echocardiography both at Hammersmith Hospital in London, and also at Hospital Bichat in Paris. He has also undertaken advanced heart failure training at Harefield Hospital.

Dr Treibel is a clinical academic cardiologist with specialist interest in valvular heart disease, heart failure and multimodality imaging. He is a BHF Intermediate Clinical Research Fellow and Associate Professor in Cardiology at UCL; Honorary Consultant Cardiologist at Barts Health. He is the clinical lead for CMR at Barts Heart Centre. His main research work focuses on the mechanisms of excess mortality in patients with valvular heart disease despite successful valve replacement. He investigates myocardial fibrosis in heart valve disease using multi-modality imaging including cardiovascular magnetic resonance, cardiac CT and echocardiography. His aim is to improve outcomes for patients with valvular heart disease by developing clinical trials in this field.

Dr Pankaj Garg is an Associate Professor in Cardiovascular Medicine at the University of East Anglia, Norwich, UK and an honorary Consultant Cardiologist at Norfolk and Norwich University Hospitals. After completing his BHF-funded PhD at Leeds (2017), he was awarded the NIHR Clinical Lectureship programme at the University of Sheffield. In 2020, he was awarded the Wellcome Trust Clinical Research Career Development Fellowship. His research focus is cardiovascular haemodynamics and Cardiac Magnetic Resonance Imaging. His ambition is to discover and advance a better understanding of the interface between cardiovascular flow, pressures and cardiac remodelling. He has received 20 national/international awards and has published >175 peer-reviewed papers.

Marina’s special expertise is Cardiac MRI for adults and children with congenital and inherited heart disease. She has published clinical research and has continually helped to educate junior and senior trainees. After medical school in Perth, Western Australia, Marina completed a PhD in Infectious Diseases and trained in clinical paediatrics in Oxford, UK. She then trained further in paediatric cardiology and took a post as Consultant and Echocardiography Lead at the Royal Children’s Hospital in Melbourne, Australia. After moving back to the UK in 2006, Marina worked as Clinical Lead for Cardiac MRI at Great Ormond St Hospital in London, helping to build a leading service, scanning more than 1000 paediatric and adult patients with congenital heart disease per year. In 2019 Marina began work as Clinical Lead for Adult Congenital Heart Disease at Papworth Hospital and since January 2021 she is concentrating on developing congenital and structural cardiac MRI services in East Anglia, both at Norwich and Peterborough. She is Honorary Senior Lecturer at the University of East Anglia.

Jonathan is a University Lecturer at the University of Cambridge and an Honorary Consultant Cardiothoracic Radiologist at the Royal Papworth Hospital. His research interests lie in the use of cardiovascular CT and MRI for better understanding how these can be used to improve patient treatment and outcomes in structural and coronary artery disease.  He also sits on the guideline committee of the SCCT, the Certification and Accreditation Committee of the EACVI and Diagnostics Advisory Committee of NICE.

Dr Peter Swoboda is a Consultant Cardiologist and British Heart Foundation funded researcher at the University of Leeds. He leads the clinical CMR service in Mid Yorkshire Hospitals which performs over 1000 scans per year and hosts a full-time cross-sectional imaging fellowship. His CMR research involves using both new and established imaging techniques to understand the mechanisms of cardiac risk in athletes. He also works on multi-centre trials of cardiovascular imaging to use imaging to improve patient experience and outcomes in conditions including heart failure and ischaemic heart disease.

Dr Anvesha Singh is an Associate Professor and Honorary Consultant Cardiologist at the University of Leicester, currently funded by an NIHR Advanced Fellowship. She is also the Director of the NIHR Integrated Academic Training programme in Leicester and the British Society of CMR Research Group Lead. She leads clinical and translational research in the field of Cardiology. Her research interests include using imaging and blood biomarkers to improve risk stratification in patients with aortic stenosis, using mixed methods in research, and use of real-world datasets to understand the epidemiology of diseases.